Effect of treatment regimen of the rheumatoid arthritis patients on the risk of coronavirus disease 2019 by modulating the inflammatory mediators.

Bagheri-Hosseinabadi, Zahra; Dehghani, Alireza; Lotfi, Mohammad Amin; Abbasifard, Mitra

Bagheri-Hosseinabadi, Zahra; Dehghani, Alireza; Lotfi, Mohammad Amin; Abbasifard, Mitra.

Afiliação

Bagheri-Hosseinabadi Z; Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Dehghani A; Department of Clinical Biochemistry, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Lotfi MA; Department of Internal Medicine, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Abbasifard M; Department of Internal Medicine, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Inflammopharmacology ; 31(6): 3021-3028, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37453023

Assuntos

Artrite Reumatoide; COVID-19; Humanos; Etanercepte/uso terapêutico; Mediadores da Inflamação/análise; Interleucina-6; Estudos Retrospectivos; Estudos Transversais; Teste para COVID-19; Citocinas; Fator de Necrose Tumoral alfa

Palavras-chave

Coronavirus disease 2019; Cytokine; Etanercept; Inflammation; Rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article